Stockscreener 앱 받기
6.215
2.30%
0.135
전일 마감가:
$6.08
열려 있는:
$6.08
하루 거래량:
60,701
Relative Volume:
0.06
시가총액:
$484.60M
수익:
$14.79M
순이익/손실:
$-102.44M
주가수익비율:
-2.0444
EPS:
-3.04
순현금흐름:
$-91.73M
1주 성능:
-4.60%
1개월 성능:
+20.54%
6개월 성능:
-6.89%
1년 성능:
+57.87%
1일 변동 폭
$6.06
$6.33
1주일 범위
$5.71
$7.33
52주 변동 폭
$2.41
$7.37
솔리드 바이오 Stock (SLDB) Company Profile
명칭
Solid Biosciences Inc
전화
617-337-4680
주소
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Compare SLDB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLDB
Solid Biosciences Inc
|
6.22 | 473.69M | 14.79M | -102.44M | -91.73M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.42 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
797.23 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
839.43 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.72 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
350.58 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
솔리드 바이오 Stock (SLDB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-04 | 개시 | Needham | Buy |
| 2025-06-26 | 개시 | Citigroup | Buy |
| 2025-01-08 | 개시 | Truist | Buy |
| 2024-12-13 | 개시 | Wedbush | Outperform |
| 2024-12-10 | 개시 | JMP Securities | Mkt Outperform |
| 2024-07-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-06-24 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-05-31 | 재개 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | William Blair | Outperform |
| 2024-03-15 | 개시 | Citigroup | Buy |
| 2024-03-14 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-12-08 | 개시 | H.C. Wainwright | Buy |
| 2021-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-05-27 | 개시 | Jefferies | Buy |
| 2021-03-16 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2020-07-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-05-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-11 | 개시 | Evercore ISI | Outperform |
| 2019-08-29 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2019-08-19 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-08-16 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-05-14 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2019-05-14 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-02-08 | 업그레이드 | Citigroup | Sell → Neutral |
| 2019-02-08 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2018-11-06 | 개시 | Citigroup | Sell |
| 2018-09-06 | 개시 | Credit Suisse | Neutral |
모두보기
솔리드 바이오 주식(SLDB)의 최신 뉴스
Solid Biosciences (SLDB) Gets a Buy from Wedbush - The Globe and Mail
Citizens reiterates Market Outperform rating on Solid Biosciences stock By Investing.com - Investing.com Nigeria
Citizens reiterates Market Outperform rating on Solid Biosciences stock - Investing.com
Solid Biosciences advances Duchenne treatment with FDA alignment By Investing.com - Investing.com South Africa
Solid Biosciences: Positive FDA Meeting SGT-003 Sets Up Next Milestones (NASDAQ:SLDB) - Seeking Alpha
Needham Reiterates Buy Rating for Solid Biosciences (SLDB) at $1 - GuruFocus
Needham & Company LLC Reaffirms Buy Rating for Solid Biosciences (NASDAQ:SLDB) - MarketBeat
Solid Biosciences (SLDB) Gains FDA Alignment for Duchenne Trial - GuruFocus
Solid Biosciences Receives Positive FDA Feedback - Intellectia AI
Solid Biosciences To Dose First Patient In IMPACT DUCHENNE Phase 3 Trial In Q1'26 - Nasdaq
Solid Biosciences stock rises after FDA alignment on Phase 3 trial design - Investing.com Australia
Solid Biosciences (SLDB) Advances Duchenne Therapy with FDA Support - GuruFocus
Solid Biosciences Aligns With FDA on Phase 3 Trial Design for Duchenne Muscular Dystrophy Gene Therapy - marketscreener.com
Solid Bio, FDA agree on trial for Duchenne drug (SLDB:NASDAQ) - Seeking Alpha
Solid Biosciences advances Duchenne treatment with FDA alignment - Investing.com
Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy - The Manila Times
Merger Talk: Why is Solid Biosciences Inc. stock going upWeekly Stock Analysis & Safe Entry Point Identification - baoquankhu1.vn
Death Cross: What are Solid Biosciences Incs earnings expectations2025 Trade Ideas & Fast Entry Momentum Alerts - baoquankhu1.vn
Solid Biosciences CTO Herzich sells $70k in SLDB stock By Investing.com - Investing.com Canada
Solid Biosciences chief regulatory officer sells $79,544 in SLDB By Investing.com - Investing.com UK
Solid Biosciences CMO Brooks sells $81k in shares By Investing.com - Investing.com South Africa
Solid Biosciences chief regulatory officer sells $79,544 in SLDB - Investing.com India
Solid Biosciences CTO Herzich sells $70k in SLDB stock - Investing.com
Solid Biosciences CEO Cumbo sells $315,092 in stock By Investing.com - Investing.com Canada
Ilan Ganot, Solid Biosciences director, sells $46k in shares By Investing.com - Investing.com UK
Ilan Ganot, Solid Biosciences director, sells $46k in shares - Investing.com
Solid Biosciences CEO Cumbo sells $315,092 in stock - Investing.com
Solid Biosciences (NASDAQ:SLDB) CFO Kevin Tan Sells 14,783 Shares - MarketBeat
Insider Selling: Solid Biosciences (NASDAQ:SLDB) CEO Sells 48,913 Shares of Stock - MarketBeat
Solid Biosciences Flies Ahead of Summit - Baystreet.ca
Solid Biosciences to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Solid Biosciences Inc. (NASDAQ:SLDB) Sees Large Decline in Short Interest - MarketBeat
Solid Biosciences COO Howton sells $243k in shares By Investing.com - Investing.com UK
Solid Biosciences (NASDAQ:SLDB) CFO Kevin Tan Sells 26,837 Shares - MarketBeat
Alexander Cumbo Sells 80,258 Shares of Solid Biosciences (NASDAQ:SLDB) Stock - MarketBeat
Gabriel Brooks Sells 28,335 Shares of Solid Biosciences (NASDAQ:SLDB) Stock - MarketBeat
Solid Biosciences (NASDAQ:SLDB) COO Sells $243,245.24 in Stock - MarketBeat
Paul Herzich Sells 26,250 Shares of Solid Biosciences (NASDAQ:SLDB) Stock - MarketBeat
Solid Biosciences CFO sells $172k in shares By Investing.com - Investing.com UK
Solid Biosciences CFO sells $172k in shares - Investing.com
Solid Biosciences COO Howton sells $243k in shares - Investing.com
Solid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
EPS Watch: Can Vail Resorts Inc sustain earnings growth2025 Technical Patterns & High Win Rate Trade Alerts - baoquankhu1.vn
솔리드 바이오 (SLDB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
솔리드 바이오 주식 (SLDB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cumbo Alexander | President and CEO |
Feb 04 '26 |
Sale |
6.44 |
48,913 |
315,093 |
222,018 |
| Ganot Ilan | Director |
Feb 04 '26 |
Sale |
6.44 |
7,205 |
46,414 |
25,271 |
| Tan Kevin | CFO & Treasurer |
Feb 04 '26 |
Sale |
6.44 |
14,783 |
95,231 |
94,201 |
| Brooks Gabriel | Chief Medical Officer |
Feb 04 '26 |
Sale |
6.44 |
12,616 |
81,271 |
84,092 |
| Hanrahan Jessie | Chief Regulatory Officer |
Feb 04 '26 |
Sale |
6.44 |
12,348 |
79,545 |
70,327 |
| Herzich Paul | Chief Technology Officer |
Feb 04 '26 |
Sale |
6.44 |
10,905 |
70,249 |
69,067 |
0.64%
0.44%
자본화:
|
볼륨(24시간):